To determine the change over time in circulating cell free DNA (cfDNA) in patients with locally advanced non-small cell lung cancer (NSCLC) during chemo-radiotherapy. Furthermore, the possibility for detection of circulating cell free tumor DNA (ctDNA) was assessed using shallow whole genome sequencing (sWGS) and size selection.
Figure 1. Representative PET/CT and CBCT scans and fluctuation in cfDNA concentration during radiation therapy in adenocarcinoma patients (AC) and patients with squamous cell carcinoma (SCC). Representative scans on corresponding time points are shown for AC
and for SCC (Patient 8) . Conclusion cfDNA remain stable during the first 2 hours after a treatment fraction. However, based on the sWGS profiles, ctDNA represented only a minor fraction of cfDNA in this group of patients. The detection sensitivity of genomic alterations in ctDNA strongly increases by applying size selection. 
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Purpose or Objective
Evidence is emerging that the heart is more radiosensitive than previously assumed [1] [2] . However, only delineations on the average projection or 3D CT scans are used for treatment planning. Therefore the motion of this organ due to respiration and contraction is not accounted for. In this pilot study, we assessed how representative the delineations based on the 3D CT scan, average (AVG) and maximum intensity projections (MIP) are.
Material and Methods
Both 3D and 4D CT scans for 10 lung cancer patients treated by SABR were used in this study. Median delineations, derived from 3 independent observers following a previously agreed protocol, were calculated on the 3D CT, AVG, MIP and 25% exhale scans. Delineations on each 4D phase scan (n=8) were created by propagating the median 25% exhale contours using RayStation v5.99. The volume representing the maximum extent of motion was estimated as the union of all 4D phase delineations (U4D), see figure 1 for an example. Surface distances from the U4D to 3D, AVG, MIP volumes were calculated. Distances in the most extreme surface points (1cm most superior/inferior, 10% most right/left/anterior/posterior) are reported. Figure 2 shows the distances for the most extreme surface points, for each delineation and direction (left-right, anterior-posterior and superior-inferior) summarized for all patients. From the three delineations, MIP is the 'closest' to the maximum extent of motion, followed by AVG and 3D (smaller boxes and closer to zero).
Results
Conclusion
None of the delineations represented the heart's maximum extent of motion; the MIP was the 'most representative' volume. Current work includes determining the margin required for any of the delineations to better represent the maximum extent of motion. Research including dosimetric measurements and inter-observer variability is needed to determine the relevance of creating a planning organ at risk volume (PRV) of the heart. 
Purpose or Objective
Radiation-related lymphopenia (RIL) is associated with inferior clinical outcomes in lung cancer patients treated with radiation (RT) and immune checkpoint inhibitors (ICIs) following RT. This study was performed to investigate whether fractionation regime affects the peripheral total lymphocyte counts (TLCs) in definitive concurrent chemoradiotherapy (CCRT) for unresectable stage III non-small lung cancer (NSCLC).
Material and Methods
We retrospectively reviewed 118 patients undergoing definitive CCRT for stage III NSCLC. Dose given to tumor and fractionation received determined by doctor and the intention from patients. The baseline of TLCs was defined as the value measured within one week before RT and a lymphocyte nadir was calculated as the minimum value measured during period of definitive RT. Patients were categorized into three groups. Group A received 2.0 -2.2 Gy per fraction (ConRT), while group B received 2.3-2.8
Gy per fraction (moderately HypoRT, mHypoRT), and group C received 3 Gy per fraction Gy (HypoRT , P= 0.001) while there were no difference in gross tumor volume between groups (P = 0.395). Three groups had similar median baseline of TLCs (P = 0.959). During radiation, 70.59% of mHypoRT patients had severe lymphopenia (ie,TLC <500 cells/µl) vs 48.08% of ConRT patients, and 37.50% of HypoRT patients (P < 0.021). Multivariate liner analyses demonstrated that lower baseline TLCs (P < 0.001), higher mean lung dose (P = 0.004) and mHypoRT (P = 0.014) were significantly risk factors of RIL. Higher post-RT TLCs was associated with improved progression-free survival (hazard ratio [HR]: 0.585; 95% confidence interval: 0.369-0.926; P= 0.022) regardless of fractionation regime.
Conclusion
HypoRT may be more appropriate fractionation regime in definitive concurrent chemoradiotherapy for unresectable stage III non-small lung cancer (NSCLC) as it brings less severe RIL compared with mHypoRT and higher radiation dose compared with ConRT. Further large-scale studies are needed to confirm our findings.
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